Lasso peptide Felipeptin A2

General Information


DRACP ID  DRACP04566

Peptide Name   Lasso peptide Felipeptin A2

Sequence  GGGGRGYEYNKQCLIFC

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  6XTI 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C81H121N23O24S2

Absent amino acids  ADHMPSTVW

Common amino acids  G

Mass  215069

Pl  8.21

Basic residues  2

Acidic residues  1

Hydrophobic residues  3

Net charge  1

Boman Index  -1966

Hydrophobicity  -43.53

Aliphatic Index  45.88

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  3105

Absorbance 280nm  194.06

Polar residues  10

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33294793

Title  Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20591

DRACP is developed by Dr.Zheng's team.